Philips(PHG)

Search documents
Philips (PHG) Aids Image-Guided Treatment With New Stent System
ZACKS· 2024-06-13 15:19
In this regard, Philips' recent launch of the Duo Venous Stent System in a bid to boost its Image-Guided Therapy portfolio remains noteworthy. Expanding Portfolio & Partner Base Aid Diagnosis & Treatment Similarly, PHG also unveiled HealthSuite Imaging, an AI-enabled cloud-based Picture Archiving and Communication System, which offers high-speed remote diagnostic reading, integrated reporting and AIpowered workflow orchestration, enhancing operational efficiency and patient care. Bottom Line The strengtheni ...
Philips launches Duo Venous Stent System for treatment of symptomatic venous outflow obstruction
Newsfilter· 2024-06-12 13:00
The 12-month effectiveness endpoint for primary patency reached 90.2%, which exceeded the performance target goal of 77.3%. The 12-month primary safety endpoint of 98.7% also exceeded the corresponding performance goal of 89%. In addition, quality of life and venous functional assessments that were performed in the VIVID study – including Clinical-Etiology-Anatomy-Pathophysiology (CEAP), Venous Clinical Severity Score (VCSS), Villalta, EQ-5D-3L and VEINES scores – showed sustained improvements compared to b ...
Philips (PHG) Boosts Precision Diagnosis With AI Platform
ZACKS· 2024-06-05 16:41
Philips' (PHG) shares have gained 17.6% in the year-to-date period, outperforming the Zacks Medical sector's growth of 4.3%. The company is benefiting from strong momentum in the Diagnosis & Treatment segment on the back of its strengthening Precision Diagnosis portfolio powered by artificial intelligence (AI). The company's latest launch of an AI-enabled cardiovascular ultrasound platform testifies to the aforesaid fact. This FDA 510(k) cleared AI platform combines Philips' EPIQ CVx and Affiniti CVx ultras ...
Deep integration of proven AI tools into Philips cardiovascular ultrasound systems to better diagnose more cardiac disease patients
Newsfilter· 2024-06-04 13:00
June 4, 2024 New FDA-cleared AI-enabled applications include the industry's first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds First fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease Amsterdam, the Netherlands – Roya ...
Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations
Newsfilter· 2024-05-30 13:00
May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico's Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustain ...
Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations
GlobeNewswire News Room· 2024-05-30 13:00
May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico's Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustain ...
Philips (PHG) Boosts Medical Imaging Footprint With New Move
zacks.com· 2024-05-29 16:26
Philips (PHG) is leaving no stone unturned to strengthen its footprint in the global medical imaging market on the back of a growing customer base. Per a Mordor Intelligence report, the global medical imaging market is expected to witness a CAGR of 4.9% between 2024 and 2030. Recently, the company announced the wide availability of its VeriSight Pro 3D Intracardiac Echocardiography catheter to several Hong Kong hospitals, thereby expanding clientele for its ICE imaging technology. Philips' VeriSight Pro 3D ...
Here's Why Royal Philips (PHG) is a Strong Value Stock
zacks.com· 2024-05-24 14:45
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style S ...
Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
globenewswire.com· 2024-05-23 20:31
May 23, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the "Notes") under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025. The issue price for the Notes is 98.257% with a Coupon of 3.75%, resulting in a ...
Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
Newsfilter· 2024-05-23 20:30
May 23, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the "Notes") under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025. The issue price for the Notes is 98.257% with a Coupon of 3.75%, resulting in a ...